3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Urinary Bladder Neoplasms
1
Radiation Injuries
1
Mixed Tumor, Mesodermal
1
Gallbladder Neoplasms
1
Esophageal Squamous Cell Carcinoma
1
Esophageal Neoplasms
1
Clinical Stage I Gastric Cancer AJCC v8
1
Breast Neoplasms
1
Interventions
pembrolizumab
22
Nivolumab
14
enfortumab vedotin
12
Gemcitabine
12
Specimen Handling
10
Magnetic Resonance Spectroscopy
10
Cisplatin
9
Carboplatin
9
sacituzumab govitecan
6
avelumab
6
Docetaxel
6
atezolizumab
5
Ipilimumab
5
durvalumab
4
Paclitaxel
4
cabozantinib
3
Taxes
3
Mitomycin
3
Immunoglobulin G
3
CTLA-4 Antigen
3
tislelizumab
2
relatlimab
2
erdafitinib
2
disitamab vedotin
2
Radiosurgery
2
Platinum
2
Oxaliplatin
2
Fluorouracil
2
Disulfides
2
Cyclophosphamide
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Transitional Cell
×
Lymph Node Excision
×
90 days
×
Clear all
No trials found.